Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Midatech completes £32mm IPO in London

Executive Summary

Nanomedicines company Midatech Pharma PLC grossed £32mm ($50mm) through its IPO of 12mm shares for £2.67 on the London Stock Exchange’s AIM Market. Following the closing, the company’s major stockholders now include Woodford Fund Management (19.99%), Arrowgrass Capital Partners (5.3%), Legal & General Investment Management (4%), and Octopus Investments (3.6%).
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Site Specific
  • Biotechnology
    • Nanotechnology, Chips, etc.
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies